ImmuCell Publishes Update to Financial Calendar

By Public Technologies
  • ImmuCell expects unaudited results for the quarter ended Sept. 30, 2026, on Nov. 12, 2026, following the market close.
  • Its Form 10-Q filing is also expected Nov. 12, 2026, following the market close.
  • A conference call and webcast to review results are scheduled for Nov. 13, 2026, at 9 a.m. ET.
  • A conference call replay will be available through Nov. 20, 2026.
  • No changes are anticipated to preliminary quarterly sales results disclosed Oct. 12, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ImmuCell Corporation published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202611061605PRIMZONEFULLFEED9872564) on November 06, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk